YM.TO: Summary for YM BIOSCIENCES INC- Yahoo! Canada Finance

Skip to search.

Yahoo! Canada Finance

Wed Jun 19, 2013 2:04PM EDT - Canadian Markets close in 1 hr 56 mins

TSX

0.42% TSX Ventures 0.00%

Streaming

Ticker Tape: On

More On YM.TO

Quotes

Summary
Order Book
Options
Historical Prices

Charts

News & Info

Headlines
Company Events
Market Pulse

Company

Profile
Key Statistics
SEC Filings
Competitors
Industry
Components

Analyst Coverage

Ownership

Major Holders
Insider Transactions
Insider Roster

Financials

YM Biosciences, Inc. (YM.TO)

-Toronto

2.95 0.00(0.00%) Feb 12, 3:37PM EST

Add to Portfolio

Prev Close:	2.95
Open:	2.95
Bid:	2.95
Ask:	2.97
1y Target Est:	N/A
Beta:	N/A
Next Earnings Date:	N/A

Day's Range:	2.95 - 2.95
52wk Range:	1.43 - 2.96
Volume:	1,200
Avg Vol (3m):	13,567
Market Cap:	N/A
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A)

Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Gilead Sciences Completes Acquisition of YM BioSciencesBusiness Wire(Fri Feb 8)
Gilead Sciences completes acquisition of YM BioSciencesPR Newswire(Fri Feb 8)
Gilead Sciences completes acquisition of YM BioSciencesCNW Group(Fri Feb 8)
Gilead Sciences completes acquisition of YM BioSciencesCNW Group(Fri Feb 8)
YM BioSciences Reports Operational and Financial Results for the Second Quarter of Fiscal 2013CNW Group(Thu Feb 7)
YM BioSciences Reports Operational and Financial Results for the Second Quarter of Fiscal 2013PR Newswire(Thu Feb 7)
YM BioSciences Reports Operational and Financial Results for the Second Quarter of Fiscal 2013CNW Group(Thu Feb 7)
YM BioSciences Announces Receipt of Final Court Order Approving the Plan of Arrangement with Gilead SciencesCNW Group(Tue Feb 5)
YM BioSciences Announces Receipt of Final Court Order Approving the Plan of Arrangement with Gilead SciencesPR Newswire(Tue Feb 5)
YM BioSciences Announces Receipt of Final Court Order Approving the Plan of Arrangement with Gilead SciencesCNW Group(Tue Feb 5)
YM BioSciences Shareholders Approve Plan of Arrangement with Gilead SciencesCNW Group(Thu Jan 31)
YM BioSciences Shareholders Approve Plan of Arrangement with Gilead SciencesPR Newswire(Thu Jan 31)
YM BioSciences Shareholders Approve Plan of Arrangement with Gilead SciencesCNW Group(Thu Jan 31)
Biotech Industry Expected to Experience More M&A Activity in 2013Marketwired(Mon Jan 21)
Gilead Sciences to Buy YM BioSciences for $510 Millionat Bloomberg(Wed Dec 12)

» More Headlines for YM.TO

Press Releases

Gilead Sciences completes acquisition of YM BioSciencesCNW Group(Fri Feb 8)
YM BioSciences Reports Operational and Financial Results for the Second Quarter of Fiscal 2013CNW Group(Thu Feb 7)
YM BioSciences Announces Receipt of Final Court Order Approving the Plan of Arrangement with Gilead SciencesCNW Group(Tue Feb 5)

» More Press Releases for YM.TO

Must Read

Loblaw tests out new smaller discount grocery store format in CalgaryThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
Exclusive: Parmalat should cut LAG price by $151 million, report to court saysReuters(1969-12-31T18:59:59GMT-05:00)
Bank of Canada says business confidence crucial, urges patienceReuters(1969-12-31T18:59:59GMT-05:00)
Vimpelcom unit drops bid to buy Canada's Wind MobileReuters(1969-12-31T18:59:59GMT-05:00)
Cisco to invest in Israeli venture capital fundsReuters(1969-12-31T18:59:59GMT-05:00)

YM Biosciences, Inc. (YM.TO)

customize chart

Comparison

Symbol	% Chg	Mkt Cap
YM.TO	0.00%	N/A
RHHBYN.MX	1.64%	2.74T
SHP.L	0.05%	11.50B
SUNPHARMA.NS	1.10%	992.21B
GILD.MX	0.00%	1.02T

» More Competitors

Key Statistics

Forward P/E (1 yr):	N/A
P/S (ttm):	N/A
Ex-Dividend Date:	N/A

Analysts

Annual EPS Est (0-00-31) :	N/A
Quarterly EPS Est (0-00-31) :	N/A
Mean Recommendation*:	N/A
PEG Ratio (5 yr expected):	N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

YM BioSciences Inc., a drug development company, engages in developing hematology and cancer-related products. Its products include CYT387, a dual inhibitor of the JAK1 and JAK2 kinases, which has implicated in a family of hematological conditions... View More

Toolbox

Copyright © 2009 Yahoo! All rights reserved.

Quotes for NYSE, Nasdaq and NYSEAmex are Real-time and sourced from Nasdaq Last Sale when available. If not available from NLS, quotes will appear delayed from primary listing source.
See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc. Real-Time quotes provided by BATS Exchange. US Financials data provided by Edgar Online and all other Financials provided by Capital IQ. International historical chart data, daily updates, fundAnalyst estimates data provided by Thomson Financial Network. All data povided by Thomson Financial Network is based solely upon research information provided by third party analysts. Yahoo! has not reviewed, and in no way endorses the validity of such data. Yahoo! and ThomsonFN shall not be liable for any actions taken in reliance thereon.